And that the development and maintenance of Schlemm’s canal and atrial fluid efflux also require PROX-1 and Tie2 signaling, which could lead to new therapies for the treatment of glaucoma (Park et al., 2014; Kim et al., 2017). Here, TEK is linked to glaucoma.